chemyo retatrutide (LY3437943) | GCGR/GLP-1R Inhibitor Retatrutide-RUO 20MG - Planet Peptide
Description
James G
Industry experts congratulated Eli Lilly and Novo Nordisk for persisting in the GLP-1 space and discussed how the next wave of innovation is not always clear.
As a result, many members turned to diabetes-indicated GLP-1s off-label, creating shortages that impacted patients who needed them for type 2 diabetes
Bottom line: GLP-1s opened the door by proving obesity therapies can be CV disease interventions
Is glp-1 the same as Ozempic
